Background: Vitamin D has several roles, namely physiological function of calcium and bone metabolism, cell growth and differentiation, immune and cardiovascular function. Vitamin D deficiency can cause the risk of cancer. Head and neck cancer is one of the cancers that occur due to vitamin D deficiency in the body. This literature review was to asses and evaluate the impact and benefits of vitamin D supplementation for head and neck cancer. Discussion: A study found an association between vitamin D supplementation and a low risk of recurrence in conditions of high total vitamin D levels. Another study found a significant increase in quality of life (QOL). The primary mechanism of vitamin D action is mediated through binding of either 1,25(OH)2D3 (active form) or 25(OH)D (less active form) to the VDR, which is a member of the nuclear receptor superfamily of steroid and thyroid hormones with gene-regulatory and consequent anti-proliferative properties. Conclusions: Vitamin D supplementation provides a role in improving the condition of patients with head and neck cancer. Both in terms of suppressing recurrence and in terms of increasing quality of life.
INTRODUCTION
Vitamin D is a steroid hormone, consisting of cholecalciferol (vitamin D 3 ) which is an endogenous form and synthesized in the skin by the action of ultraviolet light, and ergocalciferol (vitamin D 2 ) which is an exogenous form and is obtained through consumption of food or supplements [1] [2] [3] [4] . In the liver and other tissues ergocalciferol and cholecalciferol are converted to 25 To determine vitamin D status Serum 25(OH)D was used, although the cut off value for classifying insufficiency/deficiency was inconsistent. However, a general definition for vitamin D status based on serum levels of 25(OH)D has been widely established and adopted: Deficiency < 20 ng/ml (50 nmol/l); insufficient 21-29 ng/ml (52-72 nmol/l); enough > 30 ng / ml (> 75 nmol / l) 4, 9 . According to The National Academy of Sciences recommends the following daily intakes of vitamin D : 1 to 50 years, 5 µg (200 IU); 51-70 years, 10 µg (400 IU) is older than 71 years 15 µg (600 IU). In one study, 12,5 µg (500 IU) per day was associated with 30 ng / mL 25 (OH) D levels 10 . Vitamin D has many functions in terms of suppressing cancer through its various effects as antitumor, antiproliferative, apoptosis and angiogenesis. Therefore, individuals with low serum vitamin D levels will have a high risk of 19, 20 . To assess and determine the efficacy of vitamin D supplementation in the treatment of head and neck cancer in terms of reducing the risk of recurrence and improving quality of life.
LITERATURE REVIEW
Literature search was performed in PubMed and Google Scholar databases between January 2008 until September 2018. The following keywords were used in the search "vitamin D and oral cancer" or "vitamin D head and neck cancer". Titles and abstract of each publication were repeatedly reviewed in the search process. The entire article was checked when necessary. To avoid any possible reports missed in the literature search, we reviewed references from relevant articles and related reviews to identify potensial relevant studies.
The inclusion criteria will be used for selecting articles as follows :
• English and Indonesian language articles published between January 2008 until September 2018 • Study type cohort study and randomized controlled trials (RCTs) with any dose or formulation of vitamin D intervention compared with placebo or no treatment • Head and neck cancer based on requrrance and quality of life Data extraction sumarized in 4 tables. There were two outcome measures we used in order to know the role of supplementation vitamin D in included studies. The first outcome was the requrrance of cancer and the second outcome was of quality of life.
Number of 51.543 articles we got from PubMed and Google scholar, we filter articles based on title, abstract and keywords to find 10 articles, then we read 10 articles in full text, 5 articles do not enter criteria, namely 4 articles not included in the title and 1 case study artiTabel 1. Study Characteristic Tabel 2. Sample Characteristic cle. Therefore, the author gets 5 articles that match the inclusion criteria.
The 5 articles that the research design obtained, the following were two RCT (Random- 2 . The 1,25(OH) 2 D-VDR-RXR complex binds to vitamin D-response elements in DNA which operate to initiate gene transcription. Activation of the VDR by 1,25(OH) 2 D can restore or enhance proapoptotic effects in different cancer cells through transcriptional activation of bax and p-calpain, two effective proapoptotic proteins. VDR-vitamin D activation also been demonstrated to increase mRNA expression of transforming growth factor, a potent antiproliferative cytokine in normal and early stage cancer cells; superoxide dismutase, which may reduce oxidative stress-induced DNA damage and loss to DNA repair mechanisms that contribute to carcinogenesis and inflammatory cytokine production; as well as cyclin-dependent kinase (CDK) inhibitor p21, RBL2, RBLP6 and forkhead box O (FOXO) tumour suppressors that function to counteract MAPK-mediated phosphorylation and growth 2 . VDR activation may also facilitate transcriptional repression of Bc1-2 and telomerase (pro-survival proteins), as well as CDK1 mRNA, which encodes a required protein for cellcycle progression. Suppression of vascular endothelial growth factor, responsible for angiogenesis, as well as the pro-inflammatory cyclooxygenase-2, was also observed. In addition, 1,25(OH)2D may disrupt the function of β-catenin, the terminal mediator of Wnt signalling, which activates transcription of genes whose protein products (c-Myc and cyclin D1) control cell proliferation, as well as insulin-like growth factor-stimulated tumour growth 2 . A study found an association between vitamin D supplementation and a low risk of recurrence in conditions of high total vitamin D levels 19 . Another study found a significant increase in quality of life (QOL) and Disease-Free Survival (DFS) in esophageal cancer (EC) patients who underwent esophagectomy who received vitamin D supplementation during cancer treatment and post recovery 23 . T-cell functional competence is very important to stimulate antitumor immune reactivity. However, patients with head and neck squamous cell carcinoma have low immunity. There are several immune inhibitory mechanisms mediated by HNSCC (Head and Neck Squamous Cell Carcinoma), including the induction of their immune suppressing cells that block the host's immune reactivity. This study shows that treatment of patients with advanced HN-SCC disease with vitamin D supplementation reduces the level of immune inhibitory CD34 cells in peripheral blood and simultaneously increases peripheral blood cell immune reactivi-ty 22 . Likewise, prior study said that low vitamin D levels are closely related to the risk of neck and head cancer, then he said that vitamin D supplementation significantly improved healing of erythema, lichenoid, edema, ulceration and pain in patient oral cancer 11 . There are many benefits of vitamin D for body health. Therefore, we must always keep vitamin D levels in the body in sufficient condition. In addition to providing preventive benefits in the prevention of infections, cardiovascular disorders, and cancer 26 . Vitamin D supplementation provides curative benefits in cancer patients in terms of suppressing the cancer itself, preventing recurrence and improving quality of life 11, 19, [21] [22] [23] .
CONCLUSION
Vitamin D supplementation provides a role in improving the condition of patients with head and neck cancer. Both in terms of suppressing recurrence and in terms of increasing quality of life. But unfortunately there is still few research on vitamin D supplementation on oral cancer or head and neck cancer, therefore more researchers are expected to conduct research related to the role of vitamin D, especially in terms of oral cavity health.
